Proposed

WAC 182-530-1080 Requirements for prescribing and dispensing controlled substances—Prescription monitoring program (PMP). This section identifies the steps prescribers and pharmacists must take to check an apple health client's prescription drug history in the prescription monitoring program (PMP) described in chapter 246-470 WAC, prior to prescribing a controlled substance or dispensing a controlled substance from an outpatient pharmacy.

Revised language to clarify that prescribers conduct their review before prescribing, and pharmacists conduct their check when dispensing.

Adopted

WAC 182-530-1080 Requirements for prescribing and dispensing controlled substances—Prescription monitoring program (PMP). This section identifies the steps prescribers must take before prescribing a controlled substance and the steps pharmacists must take when dispensing a controlled substance from an outpatient pharmacy to check an apple health client's prescription drug history in the prescription monitoring program (PMP) described in chapter 246-470 WAC.

Proposed

(1) PMP review required. Except as identified in subsection (4) of this section, a prescriber or pharmacist must check all of a client's current prescriptions in the PMP, including any prescriptions not paid for by apple health, before prescribing or dispensing a controlled substance.

Revised language to clarify when prescribers and pharmacists conduct their checks.

Adopted

(1) PMP review required. Except as identified in subsection (4) of this section, a prescriber, before prescribing, and a pharmacist, when dispensing, must check all of a client's current prescriptions in the PMP, including any prescriptions not paid for by apple health.

Proposed

(2) Retrieval by delegates allowed. A prescriber or pharmacist may delegate the retrieval of the client's PMP information to anyone in their practice setting with authorization to access the PMP, so long as the prescriber or pharmacist reviews all of the client's current prescriptions in the PMP before prescribing or dispensing a controlled substance.

Added "when" before "dispensing" to better clarify the timing for the pharmacist's check.

Adopted

(2) Retrieval by delegates allowed. A prescriber or pharmacist may delegate the retrieval of the client's PMP information to anyone in their practice setting with authorization to access the PMP, so long as the prescriber or pharmacist reviews all of the client's current prescriptions in the PMP before prescribing or when dispensing a controlled substance.

Proposed

(3) Documentation. The prescriber or pharmacist must document in the client's record the date and time of the:

(a) Retrieval of information from the PMP; and

(b) Review of information from the PMP.

Revised this to say "prescriber and pharmacist" to clarify that both parties must conduct PMP checks.

Adopted

(3) Documentation. The prescriber and pharmacist must document in the client's record the date and time of the:

(a) Retrieval of information from the PMP; and

(b) Review of information from the PMP.

Adopted

(4) Good faith effort exception.

(a) A prescriber, pharmacist, or their delegate must make a good faith effort to review a client's prescription drug history in the PMP.

(b) If a prescriber, pharmacist, or their delegate is unable to access the client's record in the PMP after a good faith effort, that attempt must be documented in the client's record.

(c) A prescriber or pharmacist must document the reason or reasons they were unable to conduct the check.

Removed proposed subsection (a) because it is not needed and because delegates can only retrieve, not review PMP information.

Proposed

(4) Good faith effort exception.

(a) If a prescriber, pharmacist, or their delegate is unable to access the client's record in the PMP after a good faith effort, that attempt must be documented in the client's record.

(b) A prescriber or pharmacist must document the reason or reasons they were unable to conduct the check.